|
Search & win prizes instantly - Join iRazoo Now! |
|
Tefibazumab
websites
|
|
Currently popular top ten sites for: Tefibazumab
|
|
|
|
|
|
#1
Open-Label, Dose Escalation Study of the Safety and ... Tefibazumab (Aurexis) is a humanized monoclonal antibody being evaluated as ... Plasma concentrations of tefibazumab were detected 1 h after the end of the ... aac.asm.org/cgi/content/full/49/3/959
http://aac.asm.org/cgi/content/full/49/3/959
|
|
|
#2
Phase I Dose Escalation Study To Evaluate the Safety and ... Pharmacokinetic Profile of Tefibazumab in Subjects with ... tefibazumab of from 2 to 20 mg/kg of body weight demon ... positive anti-tefibazumab plasma samples was ... aac.asm.org/cgi/reprint/50/10/3499.pdf
http://aac.asm.org/cgi/reprint/50/10/3499.pdf
|
|
|
#3
Open-label, dose escalation study of the safety and ... Tefibazumab (Aurexis) is a humanized monoclonal antibody being evaluated as ... Plasma concentrations of tefibazumab were detected 1 h after the end of the ... www.ncbi.nlm.nih.gov/pubmed/15728889
http://www.ncbi.nlm.nih.gov/pubmed/15728889
|
|
|
#4
Inhibitex is a clinical stage infections disease ... Engages in the discovery, development, and commercialization of new drugs that can prevent and treat serious infections ... Profile of Tefibazumab in Subjects ... www.inhibitex.com/Pipeline/Aurexis.htm
http://www.inhibitex.com/Pipeline/Aurexis.htm
|
|
|
#5
Aurexis® in Cystic Fibrosis Subjects Chronically Colonized ... Drug: Aurexis® (tefibazumab) Phase II. Study Type: Interventional. Study Design: ... Drug Information available for: Tefibazumab. U.S. FDA Resources ... www.clinicaltrials.gov/ct2/show/NCT00198289
http://www.clinicaltrials.gov/ct2/show/NCT00198289
|
|
|
#6
BioMed Central | PDF | Tefibazumab A- a monoclonal antibody ... Tefibazumab – a monoclonal antibody against staphylococcal infection. JF John ... Access to the full text of this article requires a subscription. ... www.biomedcentral.com/content/download/xml/cd-693728.xml
http://www.biomedcentral.com/content/download/xml/cd-693728.xml
|
|
|
#7
Characterization of a Humanized Monoclonal Antibody ... ... safety and pharmacokinetic profile of tefibazumab in subjects with end-stage ... the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of ... iai.asm.org/cgi/content/abstract/73/8/5229
http://iai.asm.org/cgi/content/abstract/73/8/5229
|
|
|
#8
Characterization of a Humanized Monoclonal Antibody ... ... and characterization of monoclonal antibody (MAb) T1-2 or tefibazumab, a ... safety and pharmacokinetic profile of tefibazumab in subjects with end-stage ... iai.asm.org/cgi/content/full/73/8/5229
http://iai.asm.org/cgi/content/full/73/8/5229
|
|
|
#9
tefibazumab ... NAME ADOPTED BY THE USAN COUNCIL: USAN TEFIBAZUMAB. PRONUNCIATION (tef ee ba' zoo mab) ... Immunoglobulin G1, anti-(Staphylococcus aureus protein ClfA ... www.ama-assn.org/ama1/pub/upload/mm/365/tefibazumab.doc
http://www.ama-assn.org/ama1/pub/upload/mm/365/tefibazumab.doc
|
|
|
#10
Microsoft PowerPoint - Hetherington-CIRAR-columbia Aurexis (tefibazumab) Clinical. Development. Summary: Aurexis Clinical Studies ... Tefibazumab. N=30 * Friedman ND. 2002; Ann Int Med; 137:791-797. Antibiotics ... cpmcnet.columbia.edu/.../CIRAR_P20/Hetherington_slides.pdf
http://cpmcnet.columbia.edu/dept/nursing/CIRAR/CIRAR_P20/Hetherington_slides.pdf
|
|
|
|
People Recommended Results
|
|
We want you to become a Razoo Reviewer. Please recommend a website you liked for
this keyword. |
|
|
|
|
|
|
|
|